KALV vs OKE · rev $13.7M vs P/E 15, rev $21.67B
Kalvista Pharmaceuticals Inc (KALV) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Latest reported OKE revenue for 2026-06-30 was $21.67B. Net income was $1.74B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
KALV currently screens at market cap $1.44B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the KALV and OKE stock pages for the full models.
Not investment advice.